Uploaded May 2026 | Updated September 2026, 2 weeks ago
Should every elevated PSA lead to a prostate biopsy? And how should men interpret statistics about prostate cancer screening and survival?
In this episode, Dr. Stephen Petteruti examines prostate cancer screening, PSA testing, and comments made by Peter Attia, MD, regarding early detection and prostate cancer management. He discusses how relative risk and absolute risk can produce very different impressions, why understanding the numbers matters, and how statistics can influence medical decision-making.
You'll learn why PSA should be viewed as a monitoring tool rather than a standalone diagnostic test, how biological variation can affect PSA results, and why factors such as inflammation, benign prostatic hyperplasia (BPH), prostatitis, prostate size, and laboratory variability should be considered before making irreversible treatment decisions.
Dr. Petteruti also reviews long-term studies comparing surgery, radiation, and active monitoring for localized prostate cancer, discusses the potential risks associated with prostate biopsy, and explains why he believes individualized decision-making is more valuable than a one-size-fits-all approach.
Whether you've been told you need a prostate biopsy, have an elevated PSA, are considering active surveillance, or simply want to better understand the evidence surrounding prostate cancer screening, this episode encourages you to look beyond headlines and ask better questions before making life-changing decisions.
The goal isn't to avoid treatment.
The goal is to understand the evidence, weigh the potential benefits and risks, and choose the path that's right for you.
In This Episode
00:00 Introduction
03:04 Understanding relative risk versus absolute risk
04:31 Fear and prostate cancer decision-making
06:30 Treatment compared with observation
08:05 Dr. Petteruti's non-biopsy approach
10:12 Where conventional prostate cancer care may fall short
12:39 Why patients deserve to hear all of their options
13:53 Considering conflicts of interest in medicine
14:51 The risks and limitations of prostate biopsy
15:51 Why you should never rush a prostate cancer decision
Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.
Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.
📚 Resources
Dr. Petteruti Men's Vitality Group
intellectualmedicine.com/membership
Fight Cancer Like a Man
amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQ
Dr. Petteruti's Newsletter
drstephenpetteruti.substack.com/subscribe
Podcast Show Notes
intellectualmedicine.com/podcast-notes
🌐 Learn More
Dr. Stephen Petteruti
drstephenpetteruti.com
Intellectual Medicine
intellectualmedicine.com
📱 Connect with Dr. Petteruti
Instagram
instagram.com/dr.stephenpetteruti
Facebook
facebook.com/dr.stephenpetteruti
🎧 Listen to the Podcast
Apple Podcasts
podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409
Spotify
open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1
#ProstateCancer #ProstateBiopsy #CancerFacts
Disclaimer:
The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.
Should every elevated PSA lead to a prostate biopsy? And how should men interpret statistics about prostate cancer screening and survival?
In this episode, Dr. Stephen Petteruti examines prostate cancer screening, PSA testing, and comments made by Peter Attia, MD, regarding early detection and prostate cancer management. He discusses how relative risk and absolute risk can produce very different impressions, why understanding the numbers matters, and how statistics can influence medical decision-making.
You'll learn why PSA should be viewed as a monitoring tool rather than a standalone diagnostic test, how biological variation can affect PSA results, and why factors such as inflammation, benign prostatic hyperplasia (BPH), prostatitis, prostate size, and laboratory variability should be considered before making irreversible treatment decisions.
Dr. Petteruti also reviews long-term studies comparing surgery, radiation, and active monitoring for localized prostate cancer, discusses the potential risks associated with prostate biopsy, and explains why he believes individualized decision-making is more valuable than a one-size-fits-all approach.
Whether you've been told you need a prostate biopsy, have an elevated PSA, are considering active surveillance, or simply want to better understand the evidence surrounding prostate cancer screening, this episode encourages you to look beyond headlines and ask better questions before making life-changing decisions.
The goal isn't to avoid treatment.
The goal is to understand the evidence, weigh the potential benefits and risks, and choose the path that's right for you.
In This Episode
00:00 Introduction
03:04 Understanding relative risk versus absolute risk
04:31 Fear and prostate cancer decision-making
06:30 Treatment compared with observation
08:05 Dr. Petteruti's non-biopsy approach
10:12 Where conventional prostate cancer care may fall short
12:39 Why patients deserve to hear all of their options
13:53 Considering conflicts of interest in medicine
14:51 The risks and limitations of prostate biopsy
15:51 Why you should never rush a prostate cancer decision
Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.
Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.
📚 Resources
Dr. Petteruti Men's Vitality Group
intellectualmedicine.com/membership
Fight Cancer Like a Man
amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQ
Dr. Petteruti's Newsletter
drstephenpetteruti.substack.com/subscribe
Podcast Show Notes
intellectualmedicine.com/podcast-notes
🌐 Learn More
Dr. Stephen Petteruti
drstephenpetteruti.com
Intellectual Medicine
intellectualmedicine.com
📱 Connect with Dr. Petteruti
instagram.com/dr.stephenpetteruti
facebook.com/dr.stephenpetteruti
🎧 Listen to the Podcast
Apple Podcasts
podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409
Spotify
open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1
#ProstateCancer #ProstateBiopsy #CancerFacts
Disclaimer:
The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.
